UniProtKB/Swiss-Prot Q7RTR8: Variant p.Tyr175Phe

Taste receptor type 2 member 42
Gene: TAS2R42
Feedback?

Variant information Variant position:

175 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Tyrosine (Y) to Phenylalanine (F) at position 175 (Y175F, p.Tyr175Phe). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Similar physico-chemical property. Both residues are large size and aromatic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs35969491 [ dbSNP | Ensembl ]

Sequence information Variant position:

175 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

314 The length of the canonical sequence.
Location on the sequence:

SLNIIDKSNLTLYLDESKTL Y DKLSILKTLLSLTSFIPFSL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         SLNIIDKSNLTLYLDESKTLYDKLSILKTLLSLTSFIPFSL

Gorilla                       SLNIIDKSSLTLYLDESKTLYDKLSILKTLLSLTSFIPFSL

Rhesus macaque                SLNIIDKSNLTLYLDESKTPYDKLSLLKILLSLNSFIPFSL

Chimpanzee                    SLNIIDKSNLTLYLDESKTVYDKLSILKTLLSLTSFIPFSL

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 314	Taste receptor type 2 member 42
Topological domain	149 – 187	Extracellular
Glycosylation	163 – 163	N-linked (GlcNAc...) asparagine

Literature citations
The finished DNA sequence of human chromosome 12.
Scherer S.E.; Muzny D.M.; Buhay C.J.; Chen R.; Cree A.; Ding Y.; Dugan-Rocha S.; Gill R.; Gunaratne P.; Harris R.A.; Hawes A.C.; Hernandez J.; Hodgson A.V.; Hume J.; Jackson A.; Khan Z.M.; Kovar-Smith C.; Lewis L.R.; Lozado R.J.; Metzker M.L.; Milosavljevic A.; Miner G.R.; Montgomery K.T.; Morgan M.B.; Nazareth L.V.; Scott G.; Sodergren E.; Song X.-Z.; Steffen D.; Lovering R.C.; Wheeler D.A.; Worley K.C.; Yuan Y.; Zhang Z.; Adams C.Q.; Ansari-Lari M.A.; Ayele M.; Brown M.J.; Chen G.; Chen Z.; Clerc-Blankenburg K.P.; Davis C.; Delgado O.; Dinh H.H.; Draper H.; Gonzalez-Garay M.L.; Havlak P.; Jackson L.R.; Jacob L.S.; Kelly S.H.; Li L.; Li Z.; Liu J.; Liu W.; Lu J.; Maheshwari M.; Nguyen B.-V.; Okwuonu G.O.; Pasternak S.; Perez L.M.; Plopper F.J.H.; Santibanez J.; Shen H.; Tabor P.E.; Verduzco D.; Waldron L.; Wang Q.; Williams G.A.; Zhang J.; Zhou J.; Allen C.C.; Amin A.G.; Anyalebechi V.; Bailey M.; Barbaria J.A.; Bimage K.E.; Bryant N.P.; Burch P.E.; Burkett C.E.; Burrell K.L.; Calderon E.; Cardenas V.; Carter K.; Casias K.; Cavazos I.; Cavazos S.R.; Ceasar H.; Chacko J.; Chan S.N.; Chavez D.; Christopoulos C.; Chu J.; Cockrell R.; Cox C.D.; Dang M.; Dathorne S.R.; David R.; Davis C.M.; Davy-Carroll L.; Deshazo D.R.; Donlin J.E.; D'Souza L.; Eaves K.A.; Egan A.; Emery-Cohen A.J.; Escotto M.; Flagg N.; Forbes L.D.; Gabisi A.M.; Garza M.; Hamilton C.; Henderson N.; Hernandez O.; Hines S.; Hogues M.E.; Huang M.; Idlebird D.G.; Johnson R.; Jolivet A.; Jones S.; Kagan R.; King L.M.; Leal B.; Lebow H.; Lee S.; LeVan J.M.; Lewis L.C.; London P.; Lorensuhewa L.M.; Loulseged H.; Lovett D.A.; Lucier A.; Lucier R.L.; Ma J.; Madu R.C.; Mapua P.; Martindale A.D.; Martinez E.; Massey E.; Mawhiney S.; Meador M.G.; Mendez S.; Mercado C.; Mercado I.C.; Merritt C.E.; Miner Z.L.; Minja E.; Mitchell T.; Mohabbat F.; Mohabbat K.; Montgomery B.; Moore N.; Morris S.; Munidasa M.; Ngo R.N.; Nguyen N.B.; Nickerson E.; Nwaokelemeh O.O.; Nwokenkwo S.; Obregon M.; Oguh M.; Oragunye N.; Oviedo R.J.; Parish B.J.; Parker D.N.; Parrish J.; Parks K.L.; Paul H.A.; Payton B.A.; Perez A.; Perrin W.; Pickens A.; Primus E.L.; Pu L.-L.; Puazo M.; Quiles M.M.; Quiroz J.B.; Rabata D.; Reeves K.; Ruiz S.J.; Shao H.; Sisson I.; Sonaike T.; Sorelle R.P.; Sutton A.E.; Svatek A.F.; Svetz L.A.; Tamerisa K.S.; Taylor T.R.; Teague B.; Thomas N.; Thorn R.D.; Trejos Z.Y.; Trevino B.K.; Ukegbu O.N.; Urban J.B.; Vasquez L.I.; Vera V.A.; Villasana D.M.; Wang L.; Ward-Moore S.; Warren J.T.; Wei X.; White F.; Williamson A.L.; Wleczyk R.; Wooden H.S.; Wooden S.H.; Yen J.; Yoon L.; Yoon V.; Zorrilla S.E.; Nelson D.; Kucherlapati R.; Weinstock G.; Gibbs R.A.;
Nature 440:346-351(2006)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]; VARIANTS PHE-175 AND SER-196;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.